HALOPV is already a global Pharmacovigilance (drug safety) platform with unrivalled features for local regulatory compliance, e.g. to US, Europe, China, Canada, India and Korea.
We are now taking the next steps, to also cover Japanese reporting capabilities for the local regulatory authority PMDA into HALOPV, for ICSRs, Devices, Aggregate Reporting and Risk Management modules.
As always, expect a fully integrated experience for end users with workflows that make sense for local as well as HQ stakeholders and automate activities where possible. Also on the near-future roadmap is a localized user interface in Japanese and other languages, so stay tuned!
